MAIA Biotechnology, Inc. (MAIA)
1.38
+0.08
(+6.15%)
USD |
NYAM |
Sep 02, 16:00
1.38
0.00 (0.00%)
After-Hours: 17:53
MAIA Biotechnology Research and Development Expense (Annual) : 14.55M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 14.55M |
| December 31, 2024 | 10.09M |
| December 31, 2023 | 11.29M |
| December 31, 2022 | 9.247M |
| Date | Value |
|---|---|
| December 31, 2021 | 3.497M |
| December 31, 2020 | 1.412M |
| December 31, 2019 | 1.912M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| TG Therapeutics, Inc. | 160.22M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Anika Therapeutics, Inc. | 25.77M |